Enanta Pharmaceuticals (ENTA) Times Interest Earned (2016 - 2025)
Historic Times Interest Earned for Enanta Pharmaceuticals (ENTA) over the last 9 years, with Q3 2025 value amounting to -$7.7.
- Enanta Pharmaceuticals' Times Interest Earned rose 3340.83% to -$7.7 in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.11, marking a year-over-year increase of 10.6%. This contributed to the annual value of -$11.11 for FY2025, which is 10.6% up from last year.
- As of Q3 2025, Enanta Pharmaceuticals' Times Interest Earned stood at -$7.7, which was up 3340.83% from -$11.68 recorded in Q2 2025.
- Enanta Pharmaceuticals' Times Interest Earned's 5-year high stood at -$7.7 during Q3 2025, with a 5-year trough of -$18.38 in Q2 2023.
- For the 3-year period, Enanta Pharmaceuticals' Times Interest Earned averaged around -$11.87, with its median value being -$11.62 (2024).
- Within the past 5 years, the most significant YoY rise in Enanta Pharmaceuticals' Times Interest Earned was 4413.84% (2024), while the steepest drop was 1835.76% (2024).
- Over the past 3 years, Enanta Pharmaceuticals' Times Interest Earned (Quarter) stood at -$10.14 in 2023, then dropped by 18.36% to -$12.0 in 2024, then skyrocketed by 35.81% to -$7.7 in 2025.
- Its Times Interest Earned stands at -$7.7 for Q3 2025, versus -$11.68 for Q2 2025 and -$14.31 for Q1 2025.